ICYMI from #BBHIC2024... we are excited to announce the following Canadian healthcare leaders as 2024 Bloom Burton Award finalists (in alphabetical order): - Roberto Bellini, former President and Chief Executive Officer, Bellus Health - Tom Frohlich, former Chief Operating Officer, Chinook Therapeutics, a Novartis Company - François Ravenelle, former President and Chief Executive Officer, Inversago Pharma Please join us on September 26, 2024 at The Ritz-Carlton, Toronto to celebrate this year’s finalists: https://bit.ly/3xJdTfC #BBAward2024
Bloom Burton & Co.
Investment Banking
Toronto, Ontario 5,254 followers
Accelerating returns in healthcare
About us
Bloom Burton & Co. is a firm dedicated to accelerating returns in the healthcare sector for both investors and companies. Bloom Burton is comprised of medical, scientific, pharmaceutical, financial, legal and capital markets professionals with significant depth of experience. Our broad expertise enables us to take a creative, innovative, and entrepreneurial approach when assisting our clients with the achievement of the right monetization events. Bloom Burton and its affiliates provide capital raising, M&A advisory, equity research, strategic advisory, as well as company creation and incubation services. Bloom Burton Securities Inc. is a member of the Canadian Investment Regulatory Organization (CIRO) and is also a member of the Canadian Investor Protection Fund (CIPF).
- Website
-
https://www.bloomburton.com/
External link for Bloom Burton & Co.
- Industry
- Investment Banking
- Company size
- 11-50 employees
- Headquarters
- Toronto, Ontario
- Type
- Privately Held
- Founded
- 2008
- Specialties
- Healthcare, Financial Services, Venture Capital, Investment Banking, Management Consulting, Mergers and Acquisitions, Equity Research, and Direct Investment
Locations
-
Primary
Get directions
181 Bay St
3410
Toronto, Ontario M5J 2T3, CA
Employees at Bloom Burton & Co.
-
Danielle P.
-
Shawn Aspden, CFA
Principal at Bloom Burton & Co.
-
Stephanie Mazzone, CPA, CA
Chief Financial Officer at Bloom Burton & Co.
-
Evelyn Pau, PhD
Biotechnology Strategy Consultant | Healthcare Investment Banking | Venture Creation | Business Development | Deal Origination | Pharmaceutical |…
Updates
-
Looking for a short and sweet summer read? Check out June’s Canada in Science research round-up out now: https://bit.ly/3LCXw8c
-
Check out hot new science compiled by Mena Abdel-Nour and shared by Philip Ostrowski for the sunny month of May: https://bit.ly/4bslLQB
-
#WeekendRead: Brian Bloom comments on the positive impact of Fusion Pharmaceuticals on the growth of Hamilton's life sciences ecosystem and it's recent acquisition by AstraZeneca (LSE, Nasdaq: AZN):
Hamilton is nudging its way into the circle of Canadian #biotech capitals fuelled by collaboration and scientific knowhow at McMaster University. Here's my take in Hamilton City Magazine.
-
Based on current demand for table sponsorship, we are already SOLD OUT for the 2024 Bloom Burton Award Gala! A huge thank you to the Canadian healthcare ecosystem for your excitement and support. Don't miss your chance to grab the remaining individual tickets available here: https://lnkd.in/gqPKxgEG #BBAward2024
-
Congratulations to Shubhankar Bhatt, CPA on his promotion to Associate, Investment Banking! From his start at the company as a co-op student in 2019 to returning as an Analyst in 2022, Shubhankar's professional growth continues at Bloom Burton with his recent CPA designation and is supported by his commitment to mentoring co-op students on the investment banking team. Learn more about Shubhankar: https://bit.ly/45abZ4g
-
-
Congratulations to Andrew Antidormi on his promotion to Vice President, Institutional Sales! Andrew joined Bloom Burton in January 2020, just prior to the start of the pandemic. Since then, he has been an invaluable partner to our clients, helping them execute a variety of transactions including block trades, new financings as well as leading non-deal roadshows. Learn more about Andrew: https://bit.ly/45bCI0v
-
-
🌧️ or ☀️, the Bloom Burton team biked the DVP last weekend in support of #BikeforBrainHealth and raised over $13K for research, innovation, care and education at Baycrest for Alzheimer’s and other dementias. #GoTeamBB!
-
-
-
-
-
3
-
-
Another M&A advisory update this week: AEterna Zentaris Inc. and Ceapro Complete Merger Transaction. Bloom Burton Securities Inc. acted as Financial Advisor to Ceapro.
Aeterna Zentaris and Ceapro Complete Merger Transaction https://bit.ly/4bYwVxa #Diagnostics #Therapeutics
Aeterna Zentaris and Ceapro Complete Merger Transaction
pressviewer.com
-
An M&A advisory update to kickstart the week: Apotex Inc. Completes Acquisition of Searchlight Pharma Inc., a leading Canadian-based Specialty Innovative Branded Pharmaceutical Company. Bloom Burton Securities Inc. acted as Financial Advisor to Searchlight Pharma Inc.
Apotex is pleased to announce the successful completion of its acquisition of Searchlight Pharma Inc., a leading Canadian specialty innovative branded pharmaceutical company. This acquisition accelerates Apotex’s growth within the specialty branded innovative pharmaceutical market, reaffirming our commitment to delivering high-quality, innovative solutions to patients and consumers around the world. Searchlight is now operating as the Specialty Pharma Division of Apotex. Learn more here: https://bit.ly/4aN6mKo
-